Profiles of microRNAs in Patients with Advanced Breast Cancer Who are Chemoresistant or Chemosensitive to Fluorouracil, Adriamycin, and Cyclophosphamide Treatment
Therefore, these findings suggest that miRNAs may serve as predictive biomarkers and potential therapeutic targets in the management of breast cancer.
Authors
- Jaime Arturo Guel-Pañola
- Eneida Turiján-Espinoza (ORCID: https://orcid.org/0000-0001-6117-0618)
- Victor Manuel Ruiz-Rodríguez (ORCID: https://orcid.org/0000-0002-4050-0734)
- Gloria Estela Hernández-Hernández
- Víctor Alejandro Paz-Rodríguez
- Diana Patricia Portales-Pérez
- Osiel Hernández-González
- Mary Carmen Gutiérrez-Gil
- José De Jesús Zermeño-Nava
Institutions
- Autonomous University of San Luis Potosí (MX)
- Hospital Central Dr. Ignacio Morones Prieto (MX)
Publication Details
- Journal
- Asian Pacific Journal of Cancer Prevention
- Published
- 2026-02-01
- DOI
- https://doi.org/10.31557/apjcp.2026.27.2.469
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00